UnitedHealth Group Incorporated (UNH)
UnitedHealthcare Unveils 1,700 Treatments No Longer Needing Prior Approval
UnitedHealth Group's United Healthcare health insurance business said 1,700 diagnostic codes tied to treatments and procedures will soon no longer require prior approval.
Here's Why UnitedHealth Group (UNH) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
CVS vs. UNH: Which Health Insurance Stock Has More Upside Now?
UnitedHealth Group's stronger six-month return, improving UnitedHealthcare and Optum results and attractive valuation make it the better buy.
UnitedHealth vs. Elevance: Which Managed-Care Stock Is a Better Buy?
UNH outpaces ELV with stronger earnings prospects, improving Medicare profitability, greater upside and a more favorable risk-reward profile.
Zacks Industry Outlook UnitedHealth, The Cigna, Humana, Centene and Molina
UnitedHealth, The Cigna, Humana, Centene and Molina have been highlighted in this Industry Outlook article.
Is UnitedHealth Finding a Better Path to Medicare Advantage Growth?
UNH is prioritizing Medicare Advantage profitability over membership growth, using tighter benefits, pricing and cost controls to improve margins.
UnitedHealth Stock Looks Reasonable at 18.39X P/E: Should You Buy Now?
UNH's improving medical costs, higher EPS estimates and capital returns support its recovery, but regulatory risks remain.
Wall Street Bulls Look Optimistic About UnitedHealth (UNH): Should You Buy?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Can UNH's Lower Medical Costs Sustain the Earnings Recovery?
UnitedHealth's lower medical costs are fueling an earnings recovery, but rising commercial costs and 2027 pricing decisions could test its durability.
UnitedHealth's Medicare Recovery Is Accelerating And Has More Room To Run
Medicare Advantage cost trends are running below the original 10% assumption, while 2026 Medicare margins are expected to be above 3%. UnitedHealthcare's operating earnings outlook increased to at least $12 billion, while adjusted EPS guidance rose to $19.50–$20. UNH trades at 20.6x 2026E earnings and 18.1x 2027E, while consensus EPS reaches $22.44 in 2027.
Why UnitedHealth Group (UNH) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Is UnitedHealth Stock Still a Buy in August After Its Q2 Beat Last Month?
UnitedHealth Group (NYSE: UNH | UNH Price Prediction) reported Q2 2026 results on July 16, and the numbers cleared even the higher end of Wall Street's expectations.
